๐
Trabectedin Accord
trabectedin
Sarcoma;Ovarian Neoplasms
โ
Authorised
Generic
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Trabectedin Accord is indicated for the treatment of adult patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. Efficacy data are based mainly on liposarcoma and leiomyosarcoma patients. Trabectedin Accord in combination with pegylated liposomal doxorubicin (PLD) is indicated for the treatment of patients with relapsed platinum-sensitive ovarian cancer.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/trabectedin-accord